NuCana PLC Company Insiders
| NCNA Stock | USD 4.00 0.19 4.99% |
NuCana PLC employs about 25 people. The company is managed by 11 executives with a total tenure of roughly 22 years, averaging almost 2.0 years of service per executive, having 2.27 employees per reported executive. Analysis of NuCana PLC's management performance can provide insight into the company performance.
| Hugh Griffith CEO CEO, Founder, Director |
| Christopher Wood Chairman Chairman of the Board, Co-Founder & Chief Medical Officer |
NuCana |
NuCana PLC's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with NuCana PLC's future performance. Based on our forecasts, it is anticipated that NuCana will maintain a workforce of about 30 employees by May 2024.NuCana PLC Management Team Effectiveness
The company has return on total asset (ROA) of (0.4516) % which means that it has lost $0.4516 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0351) %, meaning that it created substantial loss on money invested by shareholders. NuCana PLC's management efficiency ratios could be used to measure how well NuCana PLC manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -1.02. The current year's Return On Capital Employed is expected to grow to -2.06. At present, NuCana PLC's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 2.6 M, whereas Total Assets are forecasted to decline to about 26.4 M.As of April 30, 2024, Common Stock Shares Outstanding is expected to decline to about 42.4 M. In addition to that, Net Loss is expected to decline to about (30.3 M)
NuCana PLC Workforce Comparison
NuCana PLC is rated below average in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 1,410. NuCana PLC claims roughly 25.0 in number of employees contributing just under 2% to equities under Health Care industry.
NuCana PLC Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. NuCana PLC Price Series Summation is a cross summation of NuCana PLC price series and its benchmark/peer.
NuCana PLC Notable Stakeholders
A NuCana PLC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as NuCana PLC often face trade-offs trying to please all of them. NuCana PLC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting NuCana PLC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Hugh Griffith | CEO, Founder, Director | Profile | |
| Christopher Wood | Chairman of the Board, Co-Founder & Chief Medical Officer | Profile | |
| Rafaele Tordjman | Non-Executive Director | Profile | |
| Martin Mellish | Non-Executive Director | Profile | |
| David Harrison | Head Medicine | Profile | |
| MD FACOG | Chief Officer | Profile | |
| Donald Munoz | Chief Officer | Profile | |
| Theresa Bruce | Senior Operations | Profile | |
| Elisabeth Oelmann | Senior Development | Profile | |
| FRCS MD | Chief Officer | Profile | |
| Martin Quinn | Company Secretary | Profile |
About NuCana PLC Management Performance
The success or failure of an entity such as NuCana PLC often depends on how effective the management is. NuCana PLC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NuCana management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NuCana management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.08) | (1.02) | |
| Return On Capital Employed | (2.17) | (2.06) | |
| Return On Assets | (0.99) | (0.94) | |
| Return On Equity | (1.86) | (1.76) |
The data published in NuCana PLC's official financial statements usually reflect NuCana PLC's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of NuCana PLC. For example, before you start analyzing numbers published by NuCana accountants, it's critical to develop an understanding of what NuCana PLC's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of NuCana PLC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NuCana PLC's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in NuCana PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NuCana PLC. Please utilize our Beneish M Score to check the likelihood of NuCana PLC's management manipulating its earnings.
NuCana PLC Workforce Analysis
Traditionally, organizations such as NuCana PLC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare NuCana PLC within its industry.NuCana PLC Manpower Efficiency
Return on NuCana PLC Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 2.5M | |
| Working Capital Per Employee | 493.7K | |
| Working Capital Per Executive | 1.1M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NuCana PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade NuCana Stock refer to our How to Trade NuCana Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for NuCana Stock analysis
When running NuCana PLC's price analysis, check to measure NuCana PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NuCana PLC is operating at the current time. Most of NuCana PLC's value examination focuses on studying past and present price action to predict the probability of NuCana PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NuCana PLC's price. Additionally, you may evaluate how the addition of NuCana PLC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is NuCana PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NuCana PLC. If investors know NuCana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NuCana PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.54) | Return On Assets (0.45) | Return On Equity (1.04) |
The market value of NuCana PLC is measured differently than its book value, which is the value of NuCana that is recorded on the company's balance sheet. Investors also form their own opinion of NuCana PLC's value that differs from its market value or its book value, called intrinsic value, which is NuCana PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NuCana PLC's market value can be influenced by many factors that don't directly affect NuCana PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NuCana PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if NuCana PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NuCana PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.